ZURA BIO LIMITED Accounts Payable, Related Parties, Current
ZURA BIO LIMITED (ZURA) had Accounts Payable, Related Parties, Current of $78.89 thousand as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes
us-gaap:AccountsPayableRelatedPartiesCurrent · last filed 2023-03-28
- 2022-12-31: Accounts Payable, Related Parties, Current $78.89K.
- 2022-09-30: Accounts Payable, Related Parties, Current $48.89K.
- 2022-06-30: Accounts Payable, Related Parties, Current $102.89K.
- 2021-12-31: Accounts Payable, Related Parties, Current $2.87K.
| Period end | Accounts Payable, Related Parties, Current |
|---|---|
| 2022-12-31 | $78.89K 10-K · filed 2023-03-28 |
| 2022-09-30 | $48.89K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $102.89K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $2.87K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |